The Indian Contract Research Organization (CRO) market is presently in a vibrant phase of growth due to the rising global need for clinical trials, drug discovery and pharmaceutical research. India has a strategic advantage of its cost effective services, highly skilled workforce and diverse patient population which allows the conduct of multi-centric trials with varying genetic profiles. Given the reduction of operational costs and quicker turnarounds, global pharmaceutical and biotechnology companies are increasingly outsourcing critical functions of their research and development... >>More
Akhil Ravi, CEO, Aurigene Pharmaceutical Services
Dr. Archana Dhawan Bajaj, Gynecologist, Obstetrician and IVF Expert, Nurture IVF Clinic
Vaibhav Tewari, Co- Founder & CEO, Portea
Shweta Rai, Managing Director, Bayer Pharmaceuticals
Dr. Shirish Alurkar, Sr. Consultant - Medical Oncology, HCG Cancer Centre